CONMED (CNMD) EV/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 26.8 | 473.0 | 22.5 | 11.0 | 10.6 | 9.02 | ||
| Changes by years, y/y, % | -23% | +1 668% | -95% | -51% | -3% | -21.1% | |||
CONMED. EV/EBITDA
CONMED. EV/EBITDA, changes, %
CONMED (CNMD) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EV/EBITDA | ? | 11.2 | 10.5 | 12.5 | 10.4 | 9.02 | 9.02 | |
| Changes by years, y/y, % | -33% | -21% | +8% | -6% | -19% | |||
| Changes by quarters, q/q, % | +2% | -6% | +18% | -17% | -13% | |||